| Q35932503 | "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo |
| Q36396207 | A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system |
| Q57616893 | Advanced Engineering Approaches in the Development of PLGA-Based Nanomedicines |
| Q39444446 | Anti-P-glycoprotein conjugated nanoparticles for targeting drug delivery in cancer treatment |
| Q38665261 | Antibody-targeted biodegradable nanoparticles for cancer therapy |
| Q37851969 | Antibody-targeted nanoparticles for cancer therapy |
| Q56366210 | Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review |
| Q38194622 | Application of traditional Chinese medicine preparation in targeting drug delivery system |
| Q36375582 | Architectural layer-by-layer assembly of drug nanocapsules with PEGylated polyelectrolytes |
| Q92939192 | Bimetallic Zeolitic Imidazolate Framework as an Intrinsic Two-Photon Fluorescence and pH-Responsive MR Imaging Agent |
| Q45146497 | Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery |
| Q27665886 | Chemically self-assembled antibody nanorings (CSANs): design and characterization of an anti-CD3 IgM biomimetic |
| Q37381177 | Chemoselective ligation in the functionalization of polysaccharide-based particles |
| Q38086377 | Concepts and practices used to develop functional PLGA-based nanoparticulate systems |
| Q38180108 | Delivering colloidal nanoparticles to mammalian cells: a nano-bio interface perspective |
| Q38322466 | Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells |
| Q38067265 | Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. |
| Q37799099 | Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation |
| Q38942671 | Dual photo- and pH-responsive supramolecular nanocarriers based on water-soluble pillar[6]arene and different azobenzene derivatives for intracellular anticancer drug delivery. |
| Q35600313 | Efficient drug delivery and induction of apoptosis in colorectal tumors using a death receptor 5-targeted nanomedicine |
| Q39209045 | Enhanced antitumor activity of the photosensitizer meso-Tetra(N-methyl-4-pyridyl) porphine tetra tosylate through encapsulation in antibody-targeted chitosan/alginate nanoparticles |
| Q39934110 | Human serum albumin conjugates of 7-ethyl-10-hydroxycamptothecin (SN38) for cancer treatment. |
| Q42359777 | Improved Treatment of Pancreatic Cancer With Drug Delivery Nanoparticles Loaded With a Novel AKT/PDK1 Inhibitor |
| Q34036920 | Interfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery |
| Q33589501 | Layer-by-layer nanoencapsulation of camptothecin with improved activity. |
| Q57371981 | Mucoadhesive drug carrier based on functional-modified cellulose as poorly water-soluble drug delivery system |
| Q38136253 | Multifunctional nanoparticles for targeting cancer and inflammatory diseases. |
| Q33418086 | Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicity |
| Q36838995 | Nanomedicine in chemoradiation. |
| Q38415502 | Nanomedicine in veterinary oncology |
| Q37148172 | Nanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospects. |
| Q52604946 | Nanoparticulate Delivery System Targeted to Tumor Neovasculature for Combined Anticancer and Antiangiogenesis Therapy |
| Q38792790 | Nanotechnology and traditional medicine: challenges and opportunities |
| Q43151685 | Photodynamic therapy of fullerene modified with pullulan on hepatoma cells |
| Q37415357 | Poly(omega-pentadecalactone-co-butylene-co-succinate) nanoparticles as biodegradable carriers for camptothecin delivery |
| Q38963662 | Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22. |
| Q35061044 | Retro-inverso carbohydrate mimetic peptides with annexin1-binding selectivity, are stable in vivo, and target tumor vasculature |
| Q90150761 | Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review |
| Q34159322 | Synthesis and evaluation of indole-based chalcones as inducers of methuosis, a novel type of nonapoptotic cell death |
| Q42365964 | Targeted nanoparticles for colorectal cancer. |
| Q36934007 | Targeted polymeric therapeutic nanoparticles: design, development and clinical translation |
| Q41019222 | Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation. |
| Q38645695 | The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies. |